Methyl 4-nitrocinnamate

Methyl 4-nitrocinnamate is a potential drug candidate for the treatment of cancer. Methyl 4-nitrocinnamate is an analog of cinnamic acid and has been shown to inhibit tumor growth in experimental models. The structural modifications that have been made to methyl 4-nitrocinnamate allow it to be more potent than cinnamic acid. This compound has also shown activity against other types of cancer cells, including breast, colorectal, and prostate cancers. Methyl 4-nitrocinnamate binds to diphenolase enzymes and inhibits their activity, which may lead to its anticancer effects.